Exploring Shootin1's oncogenic role within FGFR2 gene fusions

Volkan Ergin1, Mutlu Erdoğan2, Ekrem Yaşar3

  • 1Division of Biomedical Sciences, University of California, Riverside, USA.

Abstract

Insights

A novel Fibroblast Growth Factor Receptor 2 (FGFR2)::Shootin1 (SHTN1) fusion protein drives cancer by constitutively activating FGFR2. This discovery offers new therapeutic targets for challenging malignancies like cholangiocarcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Fibroblast Growth Factor Receptor (FGFR) gene fusions are key drivers of cancer initiation and progression.
  • FGFR fusions are significant therapeutic targets, especially in difficult-to-treat cancers such as cholangiocarcinoma.

Purpose of the Study:

  • To characterize the novel FGFR2::SHTN1 fusion.
  • To identify it as a de novo chimeric protein.
  • To elucidate its oncogenic mechanism.

Main Methods:

  • Identification of FGFR2::SHTN1 fusions using cancer genomics databases.
  • Structural modeling with AlphaFold and HADDOCK, including membrane embedding.
  • Assessment of SHTN1 oligomerization and fusion protein activity via coimmunoprecipitation and gel electrophoresis.

Main Results:

  • The FGFR2::SHTN1 fusion is an in-frame joining of FGFR2 exons 1-17 and SHTN1 exons 7-17.
  • The chimeric protein retains the intact FGFR2 tyrosine kinase domain.
  • Shootin1's coiled-coil domains mediate ligand-independent dimerization and constitutive FGFR2 activation.

Conclusions:

  • FGFR2::SHTN1 is a potent oncogenic driver, particularly in cholangiocarcinoma, via constitutive FGFR2 activation.
  • This study provides the first molecular characterization of the FGFR2::SHTN1 fusion.
  • The findings advance understanding of FGFR2 fusion biology and identify a target for future diagnostics and therapies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K